Publications by authors named "Jiri Mayer"

100Publications

How to select older patients with acute myeloid leukemia fit for intensive treatment?

Hematol Oncol 2020 Aug 30. Epub 2020 Aug 30.

Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2798DOI Listing
August 2020

Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma.

Neoplasma 2020 Sep 4. Epub 2020 Sep 4.

Department of Hematology, Oncology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4149/neo_2020_200408N372DOI Listing
September 2020

Donor-derived DNA variability in fingernails of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation detected by direct PCR.

Bone Marrow Transplant 2020 06 9;55(6):1021-1022. Epub 2020 May 9.

Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-0938-xDOI Listing
June 2020

Novel Illumina-based next generation sequencing approach with one-round amplification provides early and reliable detection of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia.

Br J Haematol 2020 May 9;189(3):469-474. Epub 2020 Feb 9.

Department of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16382DOI Listing
May 2020

Clonal hierarchy of main molecular lesions in acute myeloid leukaemia.

Br J Haematol 2019 Dec 10. Epub 2019 Dec 10.

Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16341DOI Listing
December 2019

Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex.

Cell Mol Life Sci 2020 Oct 9;77(19):3885-3903. Epub 2019 Dec 9.

Department of Biology, Faculty of Medicine, Masaryk University, 62500, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00018-019-03397-7DOI Listing
October 2020

Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national study.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2019 Sep 26. Epub 2019 Sep 26.

Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5507/bp.2019.046DOI Listing
September 2019

First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.

Ann Hematol 2019 Aug 8;98(8):1961-1972. Epub 2019 May 8.

1st Department of Medicine, First Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03694-yDOI Listing
August 2019

ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.

Leuk Lymphoma 2019 06 10;60(6):1420-1428. Epub 2019 Jan 10.

a Department of Internal Medicine - Hematology and Oncology , University Hospital Brno and Faculty of Medicine, Masaryk University , Brno , Czech Republic.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2018.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2018.1542144DOI Listing
June 2019

Detection and identification of fungi in bronchoalveolar lavage fluid from immunocompromised patients using panfungal PCR.

Folia Microbiol (Praha) 2019 May 8;64(3):421-428. Epub 2018 Dec 8.

Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12223-018-00669-wDOI Listing
May 2019

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.

Haematologica 2019 05 4;104(5):955-962. Epub 2018 Dec 4.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.206797DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518910PMC
May 2019

The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients.

Arch Med Sci 2018 Oct 15;14(6):1416-1423. Epub 2018 Feb 15.

4 Department of Internal Medicine and Hematology, Charles University, Faculty Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/aoms.2018.73538DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209720PMC
October 2018

A novel germline mutation in GP1BA gene N-terminal domain in monoallelic Bernard-Soulier syndrome.

Platelets 2018 Dec 17;29(8):827-833. Epub 2018 Oct 17.

a Department of Internal Medicine- Hematology and Oncology, University Hospital Brno and Faculty of Medicine , Masaryk University , Brno , Czech Republic.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/09537104.2018.1
Publisher Site
http://dx.doi.org/10.1080/09537104.2018.1529300DOI Listing
December 2018

C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies.

Int J Hematol 2018 Dec 6;108(6):652-657. Epub 2018 Aug 6.

Central European Institute of Technology (CEITEC), University Hospital, Masaryk University, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-018-2514-3DOI Listing
December 2018

Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.

Am J Hematol 2018 10 31;93(10):E342-E345. Epub 2018 Aug 31.

Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25232DOI Listing
October 2018

Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study.

J Clin Oncol 2018 08 27;36(22):2259-2266. Epub 2018 Mar 27.

Bruce D. Cheson, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC; Neil Chua, University of Alberta, Edmonton, Alberta; Greg Dueck, British Columbia Cancer Agency, Kelowna; Laurie H. Sehn, Centre for Lymphoid Cancer, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada; Jiri Mayer, University Hospital and Masaryk University, Brno; Marek Trněný, Charles University General Hospital, Prague, Czech Republic; Kamal Bouabdallah, Centre Hospitalier Universitaire Haut-Leveque, Bordeaux; Vincent Delwail, Centre Hospitalier Universitaire de Poitiers, Poitiers; Gilles Salles, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France; Nathan Fowler, University of Texas, Houston, TX; Oliver Press, Fred Hutchinson Cancer Research Center, Seattle, WA; John G. Gribben, Queen Mary University of London, London; Anne Lennard, Newcastle University, Newcastle upon Tyne, United Kingdom; Pieternella J. Lugtenburg, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; and Günter Fingerle-Rowson, Federico Mattiello, and Andrea Knapp, F. Hoffmann-La Roche, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.3656
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.3656DOI Listing
August 2018

Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission.

Clin Lymphoma Myeloma Leuk 2018 02 7;18(2):106-113. Epub 2017 Dec 7.

Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.11.011DOI Listing
February 2018

Investigation of next-generation sequencing data of Klebsiella pneumoniae using web-based tools.

J Med Microbiol 2017 Nov 25;66(11):1673-1683. Epub 2017 Oct 25.

CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1099/jmm.0.000624DOI Listing
November 2017

Fragment analysis represents a suitable approach for the detection of hotspot c.7541_7542delCT NOTCH1 mutation in chronic lymphocytic leukemia.

Leuk Res 2017 09 7;60:145-150. Epub 2017 Aug 7.

Central European Institute of Technology (CEITEC) and Faculty of Medicine, Masaryk University, Kamenice 5, CZ-625 00 Brno, Czech Republic; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Cernopolni 9, CZ-613 00 Brno, Czech Republic. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.08.001DOI Listing
September 2017

Genesis of new allele at locus D2S1360 in leukemia patient.

Leuk Lymphoma 2017 11 3;58(11):2741-2744. Epub 2017 Apr 3.

a Department of Internal Medicine, Hematology and Oncology , Masaryk University and University Hospital Brno , Brno , Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1307363DOI Listing
November 2017

Serological Approaches.

Methods Mol Biol 2017 ;1508:209-221

Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Jihlavska 20, Brno, 62500, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6515-1_11DOI Listing
January 2018

Novel complex mutation in NPM1 gene in patient with acute myeloid leukemia.

Leuk Lymphoma 2017 03 3;58(3):746-748. Epub 2016 Aug 3.

a Department of Internal Medicine, Hematology and Oncology , University Hospital Brno , Brno , Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1213832DOI Listing
March 2017

Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis.

Blood 2016 09 1;128(12):1609-13. Epub 2016 Aug 1.

Central European Institute of Technology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-04-709519DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291297PMC
September 2016

Validation of Minim typing for fast and accurate discrimination of extended-spectrum, beta-lactamase-producing Klebsiella pneumoniae isolates in tertiary care hospital.

Diagn Microbiol Infect Dis 2016 Sep 8;86(1):44-9. Epub 2016 Mar 8.

Department of Internal Medicine - Hematology and Oncology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diagmicrobio.2016.03.010DOI Listing
September 2016

FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia.

Leuk Lymphoma 2017 02 29;58(2):399-407. Epub 2016 Jun 29.

a Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University Hospital of Cologne , Cologne , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1190966DOI Listing
February 2017

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.

J Clin Oncol 2016 07 23;34(20):2333-40. Epub 2016 May 23.

Jorge E. Cortes and Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center, Houston, TX; Neil P. Shah, University of California San Francisco School of Medicine, San Francisco, CA; Brigid Bradley-Garelik and George Manos, Bristol-Myers Squibb, Princeton, NJ; Giuseppe Saglio, University of Turin, Turin; Michele Baccarani, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy; Jiří Mayer, University Hospital Brno and Central European Institute of Technology, Masaryk University, Brno, Czech Republic; Concepción Boqué, Institut Català d'Oncologia, Hospital Duran i Reynals, L'Hospitalet, Barcelona, Spain; Charles Chuah, Singapore General Hospital, Duke-National University of Singapore Medical School, Singapore; Luis Casanova, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú;and Andreas Hochhaus, Universitätsklinikum Jena, Jena, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.8899DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118045PMC
July 2016

Rapid detection of fungal pathogens in bronchoalveolar lavage samples using panfungal PCR combined with high resolution melting analysis.

Med Mycol 2016 Oct 9;54(7):714-24. Epub 2016 May 9.

Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/mmy/myw032DOI Listing
October 2016

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.

J Natl Cancer Inst 2016 Jul 4;108(7). Epub 2016 Mar 4.

Affiliations of authors:Department of Health Policy and Management, Johns Hopkins University , Baltimore, MD (WVP); Department of Medicine (RAL) and Departments of Pediatrics and of Public Health Sciences (RMC), University of Chicago, Chicago, IL; Eshelman School of Pharmacy and Gillings School of Global Public Health, Lineberger Comprehensive Cancer Center , and Cecil G. Sheps Center for Health Services Research, University of North Carolina , Chapel Hill, NC (SBD); Department of Haematology, Hammersmith Hospital, Imperial College , London , UK (JFA); Department of Medicine (RH, SS) and Department of Hematology and Oncology (MCM), University of Heidelberg, Mannheim, Germany; Department of Haematology and Oncology, S. Orsola-Malpighi University Hospital (MB), and Department of Hematology, "L. e A. Seragnoli" (GM), University of Bologna , Bologna , Italy ; Department of Haematology and Oncology, University Hospital , Jena , Germany (EE); INSERM Centre d'Investigation Clinique (CIC) 1402, CHU de Poitiers, Poitiers, France (JG, FG); Laboratoire d'Hematologie, Universite Victor Segalen, Bordeaux, Pessac, France (FXM); Department of Internal Medicine, Hematology and Oncology, University Hospital Brno , Brno , Czech Republic (JM); Department of Hematology and Oncology, University Hospital Leipzig , Leipzig , Germany (DN); Barbara Ann Karmanos Cancer Institute, Wayne State University , Detroit, MI (CAS); Department of Medicine, Weill Cornell Medical Center , New York, NY (RTS); Uppsala University , Uppsala , Sweden (BS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948567PMC
July 2016

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.

N Engl J Med 2015 Dec 6;373(25):2425-37. Epub 2015 Dec 6.

From the University of Texas MD Anderson Cancer Center, Houston (J.A.B.); Azienda Ospedaliera Niguarda Cà Granda (A.T.) and Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele (P.G.), Milan, and the Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara (G.G.) - all in Italy; Wilmot Cancer Institute, University of Rochester, Rochester, NY (P.M.B.); Medical University of Lodz and Copernicus Memorial Hospital, Lodz (T.R.), the Department of Cancer Prevention, School of Public Health, Medical University of Silesia, Katowice (S.G.), and the Department of Hematology, University Clinical Center of Medical University of Gdansk, Gdansk (A.H.) - all in Poland; Tom Baker Cancer Centre, Calgary, AB, Canada (C.O.); Rabin Medical Center, Beilinson Hospital and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv (O.B.), and Hadassah University Hospital, Hebrew University Medical School, Jerusalem (A.P.) - both in Israel; Leeds Teaching Hospitals, St. James Institute of Oncology, Leeds (P.H.), Kings College Hospital, London (S.D.), Royal Bournemouth Hospital, Bournemouth (H.M.), and University of Oxford, Oxford (A.S.) - all in the United Kingdom; Washington University School of Medicine, St. Louis (N.L.B.); Jiangsu Province Hospital, Nanjing, China (J.L.); North Shore Hospital, Auckland, New Zealand (D. Simpson); Stanford University School of Medicine, Stanford (S.C.), City of Hope National Medical Center, Duarte (T.S.), Pharmacyclics, Sunnyvale (D. Suri, M.C., F.C., L.S., D.F.J.), and Moores Cancer Center, University of California, San Diego, San Diego (T.J.K.) - all in California; St. Vincent's Hospital, University of Melbourne (H.Q.), and Peter MacCallum Cancer Centre and St. Vincent's Hospital (C.S.T.), Melbourne, VIC, Australia; Institute of Blood Pathology and Transfusion Medicine, National Academy of Medical Sciences of Ukraine, Lviv, Ukraine (Z.M.); Norton Cancer Institute, Louisville, KY (D.A.S.);

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1509388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722809PMC
December 2015